Skip to main content
main-content

01.03.2018 | Original Article | Ausgabe 3/2018

Supportive Care in Cancer 3/2018

Mental disorder screening on cancer patients before and after radiotherapy and at the 1-month follow-up

Zeitschrift:
Supportive Care in Cancer > Ausgabe 3/2018
Autoren:
Juan Antonio Cruzado, Manuel Hernández-Blázquez

Abstract

Background

The aim was to study the accuracy of different screening tests to detect psychopathological disorders in cancer patients treated with radiotherapy before (T1) and after radiotherapy (T2), and at the 1-month follow-up (T3).

Methods

The Mini International Neuropsychiatric Interview (MINI), the Hospital Anxiety and Depression Scale (HADS), and the distress thermometer (DT) (0–10) were administered, together with a depression scale (DEPQ) (1–5), an anxiety scale (ANSQ) (1–5), and a physical symptoms questionnaire, to patients treated with radiotherapy at T1 (232 participants), T2 (130 participants), and T3 (130 participants).

Results

The accuracy of the screening tests was higher at T2, with the HADS-T test (cut-off ≥ 10) yielding the best results: sensitivity = 0.80, specificity = 0.92, with an excellent AUC (0.91). The DT test (cut-off ≥ 4) showed a sensitivity = 0.66, a specificity = 0.91, and an AUC = 0.825, and the DEPQ (cut-off > 1) yielded a sensitivity = 0.74, a specificity = 0.78, and an AUC = 0.776. The ANSQ (cut-off > 1) showed a sensitivity = 0.60, a specificity = 0.97, and an AUC = 0.831. At T1 and T3, the sensitivity tests were unsatisfactory. The increase in sensitivity at T2 may be due to an increase of physical symptoms at such time, which occurred more frequently in those patients who scored higher on screening tests and showed mental disorders.

Conclusions

The diagnostic accuracy of the screening tests was higher at T2. At this time, HADS-T proved to be a good screening instrument; whereas at T1 and T3, screening instruments were only useful to detect cases without mental disorders, but not to identify those who suffer from them.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2018

Supportive Care in Cancer 3/2018 Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise